nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Aclidinium—Tiotropium—chronic obstructive pulmonary disease	0.579	1	CrCrCtD
Mepenzolate—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.137	0.374	CbGbCtD
Mepenzolate—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.119	0.326	CbGbCtD
Mepenzolate—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.11	0.3	CbGbCtD
Mepenzolate—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.0266	CcSEcCtD
Mepenzolate—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.0203	CcSEcCtD
Mepenzolate—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.0192	CcSEcCtD
Mepenzolate—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.019	CcSEcCtD
Mepenzolate—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.0188	CcSEcCtD
Mepenzolate—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000925	0.0171	CcSEcCtD
Mepenzolate—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.000825	0.0152	CcSEcCtD
Mepenzolate—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000773	0.0143	CcSEcCtD
Mepenzolate—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.000738	0.857	CrCbGaD
Mepenzolate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000731	0.0135	CcSEcCtD
Mepenzolate—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.0134	CcSEcCtD
Mepenzolate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000704	0.013	CcSEcCtD
Mepenzolate—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.0126	CcSEcCtD
Mepenzolate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000679	0.0125	CcSEcCtD
Mepenzolate—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.0125	CcSEcCtD
Mepenzolate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000666	0.0123	CcSEcCtD
Mepenzolate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.0118	CcSEcCtD
Mepenzolate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000629	0.0116	CcSEcCtD
Mepenzolate—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00062	0.0114	CcSEcCtD
Mepenzolate—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000617	0.0114	CcSEcCtD
Mepenzolate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000613	0.0113	CcSEcCtD
Mepenzolate—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.0107	CcSEcCtD
Mepenzolate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00057	0.0105	CcSEcCtD
Mepenzolate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000565	0.0104	CcSEcCtD
Mepenzolate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.0103	CcSEcCtD
Mepenzolate—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000548	0.0101	CcSEcCtD
Mepenzolate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000543	0.01	CcSEcCtD
Mepenzolate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000535	0.00988	CcSEcCtD
Mepenzolate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.00968	CcSEcCtD
Mepenzolate—Tension—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00962	CcSEcCtD
Mepenzolate—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00962	CcSEcCtD
Mepenzolate—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00952	CcSEcCtD
Mepenzolate—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00952	CcSEcCtD
Mepenzolate—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00951	CcSEcCtD
Mepenzolate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000507	0.00937	CcSEcCtD
Mepenzolate—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00908	CcSEcCtD
Mepenzolate—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00899	CcSEcCtD
Mepenzolate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000486	0.00897	CcSEcCtD
Mepenzolate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00866	CcSEcCtD
Mepenzolate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00866	CcSEcCtD
Mepenzolate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00849	CcSEcCtD
Mepenzolate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.00848	CcSEcCtD
Mepenzolate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000453	0.00835	CcSEcCtD
Mepenzolate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00818	CcSEcCtD
Mepenzolate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00816	CcSEcCtD
Mepenzolate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00816	CcSEcCtD
Mepenzolate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.008	CcSEcCtD
Mepenzolate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000434	0.008	CcSEcCtD
Mepenzolate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.00788	CcSEcCtD
Mepenzolate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000425	0.00784	CcSEcCtD
Mepenzolate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00781	CcSEcCtD
Mepenzolate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00781	CcSEcCtD
Mepenzolate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00042	0.00775	CcSEcCtD
Mepenzolate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00771	CcSEcCtD
Mepenzolate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000416	0.00767	CcSEcCtD
Mepenzolate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00756	CcSEcCtD
Mepenzolate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00737	CcSEcCtD
Mepenzolate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000396	0.00731	CcSEcCtD
Mepenzolate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00724	CcSEcCtD
Mepenzolate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00724	CcSEcCtD
Mepenzolate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00711	CcSEcCtD
Mepenzolate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00711	CcSEcCtD
Mepenzolate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00709	CcSEcCtD
Mepenzolate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00697	CcSEcCtD
Mepenzolate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.00695	CcSEcCtD
Mepenzolate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00684	CcSEcCtD
Mepenzolate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00684	CcSEcCtD
Mepenzolate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00683	CcSEcCtD
Mepenzolate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00672	CcSEcCtD
Mepenzolate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00669	CcSEcCtD
Mepenzolate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00659	CcSEcCtD
Mepenzolate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00659	CcSEcCtD
Mepenzolate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00659	CcSEcCtD
Mepenzolate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00656	CcSEcCtD
Mepenzolate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00646	CcSEcCtD
Mepenzolate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00636	CcSEcCtD
Mepenzolate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00636	CcSEcCtD
Mepenzolate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.0063	CcSEcCtD
Mepenzolate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000338	0.00625	CcSEcCtD
Mepenzolate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00623	CcSEcCtD
Mepenzolate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00623	CcSEcCtD
Mepenzolate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00621	CcSEcCtD
Mepenzolate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.006	CcSEcCtD
Mepenzolate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000319	0.0059	CcSEcCtD
Mepenzolate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.0059	CcSEcCtD
Mepenzolate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00589	CcSEcCtD
Mepenzolate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000313	0.00577	CcSEcCtD
Mepenzolate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00574	CcSEcCtD
Mepenzolate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00574	CcSEcCtD
Mepenzolate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00562	CcSEcCtD
Mepenzolate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00557	CcSEcCtD
Mepenzolate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00557	CcSEcCtD
Mepenzolate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00542	CcSEcCtD
Mepenzolate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00529	CcSEcCtD
Mepenzolate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00529	CcSEcCtD
Mepenzolate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00518	CcSEcCtD
Mepenzolate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000276	0.0051	CcSEcCtD
Mepenzolate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00509	CcSEcCtD
Mepenzolate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00509	CcSEcCtD
Mepenzolate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00501	CcSEcCtD
Mepenzolate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00501	CcSEcCtD
Mepenzolate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.005	CcSEcCtD
Mepenzolate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.005	CcSEcCtD
Mepenzolate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00498	CcSEcCtD
Mepenzolate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00491	CcSEcCtD
Mepenzolate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.0048	CcSEcCtD
Mepenzolate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00475	CcSEcCtD
Mepenzolate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00475	CcSEcCtD
Mepenzolate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00473	CcSEcCtD
Mepenzolate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00466	CcSEcCtD
Mepenzolate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00449	CcSEcCtD
Mepenzolate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.00433	CcSEcCtD
Mepenzolate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00423	CcSEcCtD
Mepenzolate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00392	CcSEcCtD
Mepenzolate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00364	CcSEcCtD
Mepenzolate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00357	CcSEcCtD
Mepenzolate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00344	CcSEcCtD
Mepenzolate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00319	CcSEcCtD
Mepenzolate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00315	CcSEcCtD
Mepenzolate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00307	CcSEcCtD
Mepenzolate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00287	CcSEcCtD
Mepenzolate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00285	CcSEcCtD
Mepenzolate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00271	CcSEcCtD
Mepenzolate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00269	CcSEcCtD
Mepenzolate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000141	0.0026	CcSEcCtD
Mepenzolate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00257	CcSEcCtD
Mepenzolate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000136	0.0025	CcSEcCtD
Mepenzolate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00232	CcSEcCtD
Mepenzolate—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.143	CrCbGaD
Mepenzolate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00226	CcSEcCtD
Mepenzolate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00208	CcSEcCtD
Mepenzolate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000108	0.002	CcSEcCtD
Mepenzolate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00197	CcSEcCtD
Mepenzolate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00187	CcSEcCtD
